Evidence map›Paper›PMID 29521626›Full record

ArticleeLife2018

IgM and IgD B cell receptors differentially respond to endogenous antigens and control B cell fate.

Mark Noviski, James L Mueller, Anne Satterthwaite, Lee Ann Garrett-Sinha, Frank Brombacher, Julie Zikherman

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. IgMScientific reports · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Mark NoviskiBiomedical Sciences (BMS) Graduate Program, University of California San Francisco, San Francisco, United States.ORCID https://orcid.org/0000-0001-8072-1059
James L MuellerRosalind Russell and Ephraim P. Engleman Arthritis Research Center, Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, United States.
Anne SatterthwaiteDepartment of Immunology, UT Southwestern Medical Center, Dallas, United States.
Lee Ann Garrett-SinhaDepartment of Biochemistry, University at Buffalo, The State University of New York, Buffalo, United States.
Frank BrombacherInternational Center for Genetic Engineering and Biotechnology (ICGEB), Cape Town, South Africa.
Julie ZikhermanRosalind Russell and Ephraim P. Engleman Arthritis Research Center, Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, United States.ORCID http://orcid.org/0000-0002-0873-192X
University of California, San Francisco · USSouth African Medical Research Council · ZASouthwestern Medical Center · USUniversity at Buffalo, State University of New York · US

Funding

UCD Mutant Mouse Regional Resource CenterU42OD012210 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2012 to 2026
$29.2M
Dissecting unique functions of IgM and IgD BCRs in tolerance and autoimmunityR01AR069520 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ZIKHERMAN, JULIE · 2016 to 2020
$1.7M
Titrating CD45 expression in mice to study development of T cell toleranceK08AR059723 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ZIKHERMAN, JULIE · 2010 to 2014
$598k
NIAMS NIH HHS K08 AR059723NIAMS NIH HHS NIAMS K08 AR059723NIAMS NIH HHS R01 A127648NIAMS NIH HHS R01 AR069520NIH HHS U42 OD012210
6 · The paper itself

Abstract

Naive B cells co-express two BCR isotypes, IgM and IgD, with identical antigen-binding domains but distinct constant regions. IgM but not IgD is downregulated on autoreactive B cells. Because these isotypes are presumed to be redundant, it is unknown how this could impose tolerance. We introduced the Nur77-eGFP reporter of BCR signaling into mice that express each BCR isotype alone. Despite signaling strongly in vitro, IgD is less sensitive than IgM to endogenous antigen in vivo and developmental fate decisions are skewed accordingly. IgD-only

Indexed as

AnimalsAntigensAutoantibodiesB-LymphocytesCell LineageGerminal CenterImmune ToleranceImmunoglobulin DImmunoglobulin MMiceReceptors, Antigen, B-CellSignal TransductionAntigensAutoantibodiesImmunoglobulin DImmunoglobulin MReceptors, Antigen, B-Cellantibody responsesautoimmune response/diseaseB cell receptorIgDIgMimmunologyinflammationmousesignal transduction

Identifiers

PMID29521626
PMCPMC5897097
OpenAlexW2791186555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.